Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-01

Clinical Trial Update: Effect of Pectin in Chronic Kidney Disease Patients ( Stage 3 and 4 ) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of pectin in patients with stage 3-4 chronic kidney disease; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pectin (pectin)

Snippet

Sponsor: Assiut University | Conditions: Chronic Kidney Diseases | Phase 2 | Status: NOT_YET_RECRUITING